News | April 10, 2014

Novo Nordisk Brazil: World Market Leader In Diabetes Care Implements Newest PAS-X Version At One Of Its Largest Sites

NovoNordisk_Brazil.jpg

18 Production Lines and TwoLines for Packaging / Excellent Go-Live Support by Werum

Novo Nordisk, the world market leader in diabetes care, implemented PAS-X V3.1.5 successfully at their Brazilian site in Montes Claros. With 18 production lines in five process areas, including lines for formulation, filling, inspection, assembling and packaging insulin pens, and two lines for tablet packaging, Montes Claros is one of the company’s largest sites.

PAS-X was rolled out with SAP in the context of the global PS@SAP program, Novo Nordisk’s largest ever IT initiative to install a globally standardized ERP/MES solution across all production sites. Montes Claros has been the fifth site on the PAS-X rollout plan. Since PAS-X V3.1.5 covers all major functionalities out of the box, only minor customizations were made.

"Werum's support as we went live was excellent, for example putting people on site short-term and providing support whenever needed," says Roberto Soares Toledo, Novo Nordisk's project manager in Brazil. "Since PAS-X is so flexible, user-friendly, and intuitive, it's possible to begin with the basics and then build on these, learning to use PAS-X step by step."

About Werum Software & Systems AG
Werum IT Solutions AG is the internationally leading supplier of Manufacturing Execution Systems (MES) for the pharmaceutical and biopharmaceutical industries. Its PAS-X software product is used by 17 of the world’s top 30 pharmaceutical and biotech companies in more than 700 installations. Founded in 1969, the IT company employs more than 400 people at its headquarters in Lueneburg, Germany, and at nine other locations in Germany, France, Switzerland, the United States, Japan, and Singapore. For more information, visit www.pas-x.com.

SOURCE: Werum Software & Systems AG

Newsletter Signup
Newsletter Signup
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.